Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 8 | 2024 | 1892 | 1.250 |
Why?
|
| Pacemaker, Artificial | 2 | 2024 | 191 | 1.100 |
Why?
|
| Plasma Exchange | 2 | 2018 | 83 | 0.960 |
Why?
|
| Anti-Arrhythmia Agents | 4 | 2024 | 226 | 0.920 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 481 | 0.910 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 725 | 0.880 |
Why?
|
| Atrioventricular Block | 1 | 2024 | 46 | 0.810 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 65 | 0.760 |
Why?
|
| Heart Diseases | 3 | 2018 | 505 | 0.740 |
Why?
|
| Anticoagulants | 4 | 2022 | 589 | 0.710 |
Why?
|
| Cardiomyopathies | 2 | 2018 | 515 | 0.700 |
Why?
|
| Electrocardiography | 4 | 2018 | 980 | 0.670 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2020 | 19 | 0.650 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 300 | 0.640 |
Why?
|
| Cardiac Rehabilitation | 1 | 2020 | 29 | 0.630 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2024 | 129 | 0.620 |
Why?
|
| Factor Xa Inhibitors | 2 | 2018 | 59 | 0.570 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 32 | 0.570 |
Why?
|
| Hemorrhage | 2 | 2022 | 501 | 0.570 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2018 | 275 | 0.560 |
Why?
|
| Exercise Therapy | 1 | 2020 | 173 | 0.560 |
Why?
|
| Thromboembolism | 1 | 2018 | 90 | 0.530 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 276 | 0.510 |
Why?
|
| Stroke | 2 | 2022 | 1041 | 0.490 |
Why?
|
| Fontan Procedure | 2 | 2020 | 189 | 0.480 |
Why?
|
| Pulmonary Artery | 2 | 2023 | 444 | 0.480 |
Why?
|
| Cardiac Tamponade | 1 | 2015 | 37 | 0.460 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 72 | 0.450 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2020 | 252 | 0.440 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 284 | 0.430 |
Why?
|
| Coronary Vessels | 1 | 2018 | 530 | 0.430 |
Why?
|
| Pyridones | 1 | 2015 | 144 | 0.430 |
Why?
|
| Survivors | 1 | 2016 | 351 | 0.420 |
Why?
|
| Tachycardia, Supraventricular | 3 | 2022 | 110 | 0.420 |
Why?
|
| Electric Countershock | 1 | 2014 | 79 | 0.400 |
Why?
|
| Administration, Oral | 3 | 2022 | 703 | 0.390 |
Why?
|
| Pyrazoles | 1 | 2015 | 352 | 0.380 |
Why?
|
| Exercise | 1 | 2018 | 865 | 0.370 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 162 | 0.350 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 62 | 0.340 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2012 | 110 | 0.340 |
Why?
|
| Heart Rate | 3 | 2024 | 578 | 0.320 |
Why?
|
| Treatment Outcome | 10 | 2024 | 12858 | 0.310 |
Why?
|
| Transposition of Great Vessels | 2 | 2025 | 126 | 0.310 |
Why?
|
| Humans | 31 | 2025 | 130931 | 0.300 |
Why?
|
| Adult | 15 | 2025 | 31541 | 0.290 |
Why?
|
| Cardiac Catheterization | 4 | 2023 | 635 | 0.280 |
Why?
|
| Young Adult | 7 | 2025 | 10040 | 0.270 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1176 | 0.270 |
Why?
|
| Mass Screening | 1 | 2013 | 824 | 0.260 |
Why?
|
| Echocardiography | 2 | 2025 | 1135 | 0.230 |
Why?
|
| Arterial Switch Operation | 1 | 2025 | 24 | 0.230 |
Why?
|
| Retrospective Studies | 10 | 2025 | 17485 | 0.220 |
Why?
|
| Amiodarone | 1 | 2024 | 47 | 0.210 |
Why?
|
| Male | 14 | 2025 | 64823 | 0.200 |
Why?
|
| Mustard Plant | 1 | 2022 | 3 | 0.190 |
Why?
|
| Vacuum Curettage | 1 | 2022 | 4 | 0.190 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 62 | 0.190 |
Why?
|
| Heart Conduction System | 1 | 2024 | 161 | 0.190 |
Why?
|
| Sotalol | 2 | 2022 | 33 | 0.190 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2022 | 29 | 0.180 |
Why?
|
| Hospitalization | 3 | 2022 | 1925 | 0.180 |
Why?
|
| Adenosine | 1 | 2022 | 121 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 298 | 0.170 |
Why?
|
| Warfarin | 1 | 2022 | 123 | 0.170 |
Why?
|
| Female | 15 | 2025 | 70755 | 0.160 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2020 | 9 | 0.160 |
Why?
|
| Time Factors | 4 | 2024 | 6275 | 0.160 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 101 | 0.150 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 31 | 0.150 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1202 | 0.150 |
Why?
|
| Incidence | 3 | 2019 | 3327 | 0.150 |
Why?
|
| Dyspnea | 1 | 2020 | 158 | 0.150 |
Why?
|
| Heart Ventricles | 1 | 2024 | 772 | 0.150 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 88 | 0.150 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2020 | 124 | 0.150 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 74 | 0.150 |
Why?
|
| Exercise Test | 1 | 2019 | 245 | 0.150 |
Why?
|
| Nasal Sprays | 1 | 2018 | 7 | 0.140 |
Why?
|
| Hypoxia | 1 | 2020 | 246 | 0.140 |
Why?
|
| Catheter Ablation | 1 | 2022 | 311 | 0.140 |
Why?
|
| Risk Factors | 4 | 2019 | 10901 | 0.140 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 111 | 0.140 |
Why?
|
| Syncope | 1 | 2018 | 48 | 0.140 |
Why?
|
| Stents | 3 | 2020 | 775 | 0.140 |
Why?
|
| Rivaroxaban | 1 | 2018 | 48 | 0.140 |
Why?
|
| Athletic Injuries | 1 | 2018 | 68 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2018 | 126 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 2287 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 208 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 250 | 0.120 |
Why?
|
| Pericardiocentesis | 1 | 2015 | 17 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2018 | 254 | 0.120 |
Why?
|
| Adolescent | 5 | 2025 | 20814 | 0.110 |
Why?
|
| Survival Rate | 2 | 2018 | 2138 | 0.110 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 213 | 0.110 |
Why?
|
| Middle Aged | 6 | 2023 | 28735 | 0.110 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2014 | 54 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2014 | 39 | 0.100 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2014 | 133 | 0.100 |
Why?
|
| Pregnancy | 2 | 2018 | 7558 | 0.100 |
Why?
|
| United States | 4 | 2018 | 11718 | 0.100 |
Why?
|
| Athletes | 1 | 2013 | 73 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 787 | 0.090 |
Why?
|
| Transducers, Pressure | 1 | 2012 | 10 | 0.090 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2012 | 25 | 0.090 |
Why?
|
| Vascular Access Devices | 1 | 2012 | 35 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 296 | 0.090 |
Why?
|
| Heart Atria | 1 | 2014 | 335 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2012 | 120 | 0.090 |
Why?
|
| Arterial Pressure | 1 | 2012 | 130 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2025 | 5257 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2012 | 156 | 0.080 |
Why?
|
| Aged | 5 | 2022 | 21134 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 773 | 0.070 |
Why?
|
| Ischemia | 1 | 2012 | 353 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2122 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6862 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3120 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 863 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2012 | 835 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2095 | 0.070 |
Why?
|
| Prognosis | 2 | 2014 | 4930 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1904 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 1302 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1625 | 0.050 |
Why?
|
| Age Factors | 1 | 2011 | 2866 | 0.050 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 1063 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2012 | 3675 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3833 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 13210 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2018 | 62 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 170 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1220 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2017 | 130 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 174 | 0.030 |
Why?
|
| Length of Stay | 1 | 2022 | 1389 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 272 | 0.030 |
Why?
|
| Reimbursement Mechanisms | 1 | 2014 | 36 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1633 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 28 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 283 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2019 | 14945 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 202 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 5096 | 0.020 |
Why?
|
| Mesenteric Ischemia | 1 | 2012 | 30 | 0.020 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2012 | 32 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3604 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 227 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6443 | 0.020 |
Why?
|
| Patient Selection | 1 | 2014 | 724 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 129 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 293 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1441 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3433 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 584 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 760 | 0.020 |
Why?
|
| Disease Management | 1 | 2013 | 559 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 683 | 0.020 |
Why?
|
| Child | 2 | 2019 | 26098 | 0.020 |
Why?
|